EBM Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jackson, C. D.
Right arrow Articles by Turner, A. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jackson, C. D.
Right arrow Articles by Turner, A. J.
Experimental Biology and Medicine 231:794-801 (2006)
© 2006 Society for Experimental Biology and Medicine


VASCULAR AND HYPERTENSION

Expression and Localization of Human Endothelin-Converting Enzyme-1 Isoforms in Symptomatic Atherosclerotic Disease and Saphenous Vein

Carolyn D. Jackson*,1, Kay Barnes*, Shervanthi Homer-Vanniasinkam{dagger} and Anthony J. Turner*

* School of Biochemistry & Microbiology, University of Leeds, Leeds LS29JT, United Kingdom; and {dagger} Vascular Research Unit, Leeds General Infirmary, Great George Street, Leeds LS13EX, United Kingdom

To whom requests for reprints should be addressed at 1 School of Biochemistry and Microbiology, University of Leeds, Leeds LS29JT, United Kingdom. E-mail: c.d.jackson{at}bmb.leeds.ac.uk

Abstract

Endothelin-converting enzyme (ECE-1) is a critical enzyme in the production of the potent vasoconstrictor peptide endothelin (ET-1). It has previously been shown that the levels of both ET-1 and ECE-1 are raised in atherosclerosis, but the possible relevance of the isoforms of ECE-1 in these changes has not yet been investigated. The aim of this study was to examine the expression of the ECE-1a and ECE-1c isoforms in human atherosclerotic pathologies. Immunohistochemical analysis was carried out on sections from atherosclerotic and non-atherosclerotic vascular tissue using a combination of ECE-1 isoform-specific antibodies, anti–{alpha}-actin antibodies to identify smooth muscle cells (SMC) and anti-CD68 antibodies to identify macrophages. ECE-1 isoform expression was also examined in cultured SMC and in macrophages isolated from human blood. Results indicated differences in isoform expression in athero-sclerotic lesions, with distinct patterns of staining for ECE-1a and ECE-1c. ECE-1c immunoreactivity was seen in macrophages, and also correlated with actin staining. ECE-1a was also localized to macrophages and SMC. Results of this study suggest that these local changes influence the expression patterns of the ECE-1 isoforms within individual cell types. Correlation of these isoform expression patterns with the stage of atherosclerosis could provide novel indicators of disease progression.

Key Words: vasculature • atherosclerosis • endothelins







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by the Society for Experimental Biology and Medicine.